These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 26063416)

  • 1. PROX1 is involved in progression of rectal neuroendocrine tumors, NETs.
    Jernman J; Kallio P; Hagström J; Välimäki MJ; Haapasalo H; Alitalo K; Arola J; Haglund C
    Virchows Arch; 2015 Sep; 467(3):279-84. PubMed ID: 26063416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The novel WHO 2010 classification for gastrointestinal neuroendocrine tumours correlates well with the metastatic potential of rectal neuroendocrine tumours.
    Jernman J; Välimäki MJ; Louhimo J; Haglund C; Arola J
    Neuroendocrinology; 2012; 95(4):317-24. PubMed ID: 22327359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin A predicts metastatic potential of rectal neuroendocrine tumors.
    Jernman J; Välimäki MJ; Hagström J; Louhimo J; Haapasalo H; Arola J; Haglund C
    Hum Pathol; 2014 Aug; 45(8):1605-9. PubMed ID: 24824027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of PAX6 and PAX8 as immunohistochemical markers for pancreatic neuroendocrine tumors.
    Lai JP; Mertens RB; Mirocha J; Koo J; Venturina M; Chung F; Mendez AB; Kahn M; Dhall D
    Endocr Pathol; 2015 Mar; 26(1):54-62. PubMed ID: 25433656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Stem Cell-associated Marker HES77 in Rectal Neuroendocrine Tumors.
    Jernman J; Hagström J; Mäenpää H; Välimäki MJ; Haapasalo H; Nilsson O; Fermér C; Haglund C; Arola J
    Anticancer Res; 2015 Jul; 35(7):3767-72. PubMed ID: 26124320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphovascular invasion in more than one-quarter of small rectal neuroendocrine tumors.
    Kwon MJ; Kang HS; Soh JS; Lim H; Kim JH; Park CK; Park HR; Nam ES
    World J Gastroenterol; 2016 Nov; 22(42):9400-9410. PubMed ID: 27895428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rectal Neuroendocrine Tumor with Synchronous Pancreatic Metastasis: A Case Report.
    Masuoka Y; Furukawa D; Yazawa N; Izumi H; Yamada M; Mashiko T; Saito G; Okada K; Tanaka A; Suzuki T; Sadahiro S; Hirabayashi K; Nakagohri T
    Tokai J Exp Clin Med; 2018 Jul; 43(2):38-44. PubMed ID: 29961930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of CDX-2 and TTF-1 expressions in separating metastatic neuroendocrine neoplasms of unknown origin.
    Lin X; Saad RS; Luckasevic TM; Silverman JF; Liu Y
    Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):407-14. PubMed ID: 18091383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromogranin A Expression in Rectal Neuroendocrine Tumors Is Associated With More Aggressive Clinical Behavior and a Poorer Prognosis.
    Kim J; Kim JY; Oh EH; Yoo C; Park IJ; Yang DH; Ryoo BY; Ryu JS; Hong SM
    Am J Surg Pathol; 2020 Nov; 44(11):1496-1505. PubMed ID: 32735108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High PROX1 expression in gastric cancer predicts better survival.
    Laitinen A; Böckelman C; Hagström J; Kokkola A; Kallio P; Haglund C
    PLoS One; 2017; 12(8):e0183868. PubMed ID: 28854215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-L-cell immunophenotype and large tumor size in rectal neuroendocrine tumors are associated with aggressive clinical behavior and worse prognosis.
    Kim JY; Kim KS; Kim KJ; Park IJ; Lee JL; Myung SJ; Park Y; Park YS; Yu CS; Kim JC; Yu E; Jang HJ; Hong SM
    Am J Surg Pathol; 2015 May; 39(5):632-43. PubMed ID: 25724002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunohistochemical expression of islet 1 and PAX8 by rectal neuroendocrine tumors should be taken into account in the differential diagnosis of metastatic neuroendocrine tumors of unknown primary origin.
    Koo J; Zhou X; Moschiano E; De Peralta-Venturina M; Mertens RB; Dhall D
    Endocr Pathol; 2013 Dec; 24(4):184-90. PubMed ID: 24037217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear PROX1 is Associated with Hypoxia-Inducible Factor 1α Expression and Cancer Progression in Esophageal Squamous Cell Carcinoma.
    Yokobori T; Bao P; Fukuchi M; Altan B; Ozawa D; Rokudai S; Bai T; Kumakura Y; Honjo H; Hara K; Sakai M; Sohda M; Miyazaki T; Ide M; Nishiyama M; Oyama T; Kuwano H
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1566-73. PubMed ID: 26310281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Significance of Defining L-Cell Type on the Biologic Behavior of Rectal Neuroendocrine Tumors in Relation with Pathological Parameters.
    ; Sohn JH; Cho MY; Park Y; Kim H; Kim WH; Kim JM; Jung ES; Kim KM; Lee JH; Chan HK; Park DY; Joo M; Kim S; Moon WS; Kang MS; Jin SY; Kang YK; Yoon SO; Han H; Choi E
    Cancer Res Treat; 2015 Oct; 47(4):813-22. PubMed ID: 25715764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positivity for SATB2 distinguishes Islet1 positive rectal neuroendocrine tumours from pancreaticoduodenal neuroendocrine tumours.
    Mohanty SK; Tiwari A; Bhardwaj N; Chuang F; Kim E; Lugo H; Yuan X; Diffalha SA; Peralta-Venturina M; Balzer B; Dhall D
    J Clin Pathol; 2021 Sep; 74(9):582-588. PubMed ID: 32934105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prox1 transcription factor as a marker for vascular tumors-evaluation of 314 vascular endothelial and 1086 nonvascular tumors.
    Miettinen M; Wang ZF
    Am J Surg Pathol; 2012 Mar; 36(3):351-9. PubMed ID: 22067331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and prognostic value of transcription factor PROX1 in colorectal cancer.
    Skog M; Bono P; Lundin M; Lundin J; Louhimo J; Linder N; Petrova TV; Andersson LC; Joensuu H; Alitalo K; Haglund CH
    Br J Cancer; 2011 Oct; 105(9):1346-51. PubMed ID: 21970873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of SATB2, ISL1, and TTF1 to differentiate rectal from other gastrointestinal and lung well-differentiated neuroendocrine tumors.
    Zhao LH; Chen C; Mao CY; Xiao H; Fu P; Xiao HL; Wang G
    Pathol Res Pract; 2019 Jul; 215(7):152448. PubMed ID: 31133441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clusterin expression in gastrointestinal neuroendocrine tumours is highly correlated with location and is helpful in determining the origin of liver metastases.
    Mourra N; Scriva A; Mansiaux Y; Gozlan S; Bennis M; Balaton A
    Histopathology; 2014 Nov; 65(5):642-50. PubMed ID: 24807631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High VEGF serum values are associated with locoregional spread of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
    Cigrovski Berković M; Čačev T; Catela Ivković T; Marout J; Ulamec M; Zjačić-Rotkvić V; Kapitanović S
    Mol Cell Endocrinol; 2016 Apr; 425():61-8. PubMed ID: 26805636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.